Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Feb 20;75(1):25.
doi: 10.1007/s12031-025-02311-0.

Chitinase-3 Like-Protein-1 Signature in Neurological Disorders: Emphasis on Stroke

Khiany Mathias  1   2 , Richard Simon Machado  1   2 , Naíla Maciel Andrade  1 , Natalia Piacentini  1 , Carla Damasio Martins  1 , Josiane Somariva Prophiro  2 , Fabricia Petronilho  3   4
Affiliations
Review

Chitinase-3 Like-Protein-1 Signature in Neurological Disorders: Emphasis on Stroke

Khiany Mathias et al. J Mol Neurosci. .

Abstract

Chitinase-3 like-protein-1 (CHI3L1) is a protein involved in various pathological conditions, including infectious, allergic, metabolic, cardiovascular, and neurological diseases. In the central nervous system, glial cells, especially activated astrocytes, are the primary sources of CHI3L1 synthesis and secretion. In neurodegenerative diseases, such as Alzheimer's disease, elevated levels of CHI3L1 are correlated with greater cognitive decline and neuroinflammation. Regarding stroke, CHI3L1 is a relevant biomarker associated with an increased risk of adverse events and mortality, particularly in patients with elevated levels following the onset of symptoms. Overall, the presence of CHI3L1 may reflect disease severity and aid in predicting outcomes. This narrative review explores the potential role of CHI3L1 in neurological diseases, with an emphasis on stroke, and it may contribute to guiding the development of effective inhibitors, which could be an attractive therapeutic approach for treating this condition.

Keywords: CHI3L1; Neurological Diseases; Stroke; YKL-40.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics Approval: Not applicable. Consent to Participate: Not applicable. Consent for Publication: Not applicable. Competing Interests: The authors declare no competing interests.

References

    1. Bonneh-Barkay D, Wang G, Starkey A et al (2010) In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases. J Neuroinflammation 7:34. https://doi.org/10.1186/1742-2094-7-34 - DOI - PubMed - PMC
    1. Bonneh-Barkay D, Wang G, LaFramboise WA et al (2012) Exacerbation of Experimental Autoimmune Encephalomyelitis in the Absence of Breast Regression Protein 39/Chitinase 3-Like 1. J Neuropathol Exp Neurol 71:948–958. https://doi.org/10.1097/NEN.0b013e31826eaee7 - DOI - PubMed
    1. Chang M-C, Chen C-T, Chiang P-F, Chiang Y-C (2024) The Role of Chitinase-3-like Protein-1 (YKL40) in the Therapy of Cancer and Other Chronic-Inflammation-Related Diseases. Pharmaceuticals 17:307. https://doi.org/10.3390/ph17030307 - DOI - PubMed - PMC
    1. Chen X-L, Li Q, Huang W-S et al (2017) Serum YKL-40, a prognostic marker in patients with large-artery atherosclerotic stroke. Acta Neurol Scand 136:97–102. https://doi.org/10.1111/ane.12688 - DOI - PubMed
    1. Comabella M, Montalban X (2014) Body fluid biomarkers in multiple sclerosis. Lancet Neurol 13:113–126. https://doi.org/10.1016/S1474-4422(13)70233-3 - DOI - PubMed

LinkOut - more resources